Cedar Brook Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,035	Closed	-$602K	–	367
2024 Q1	$602K	Buy	1,035 +25	+2%	+$14K	0.12%	181
2023 Q4	$551K	Buy	1,010 +388	+62%	+$188K	0.12%	181
2023 Q3	$315K	Sell	622 -79	-11%	-$42.1K	0.08%	246
2023 Q2	$365K	Sell	701 -25	-3%	-$13.5K	0.09%	239
2023 Q1	$419K	Buy	726 +24	+3%	+$13.5K	0.11%	205
2022 Q4	$387K	Sell	702 -19	-3%	-$10.1K	0.11%	209
2022 Q3	$366K	Buy	721 +38	+6%	+$21.3K	0.12%	207
2022 Q2	$371K	Buy	683 +88	+15%	+$48.4K	0.12%	204
2022 Q1	$351K	Buy	595 +59	+11%	+$33.9K	0.09%	237
2021 Q4	$357K	Buy	536 +34	+7%	+$21.2K	0.09%	242
2021 Q3	$287K	Sell	502 -34	-6%	-$18.7K	0.09%	255
2021 Q2	$271K	Buy	536 +43	+9%	+$20.3K	0.08%	292
2021 Q1	$225K	Sell	493 -6	-1%	-$2.86K	0.08%	287
2020 Q4	$232K	Sell	499 -66	-12%	-$30.9K	0.08%	277
2020 Q3	$249K	Sell	565 -4	-0.7%	-$1.65K	0.1%	234
2020 Q2	$206K	Buy	+569	New	+$191K	0.09%	258